Bladder cancer Doctors in Turkey — Page 2

Dr. Yildiz has published extensively on rare cancer cases, including neuroendocrine tumors and paraneoplastic syndromes, at Medipol Mega University Hospital.

• Specializes in diagnosing and treating complex bladder cancer cases
• Authored multiple studies on rare tumor presentations
• Expert in managing cancer-related endocrine complications
• Focuses on personalized treatment approaches

Dr. Turkan Ozturk Topcu specializes in bladder cancer treatment with extensive training across top cancer centers worldwide.

• Medical oncology specialist with 18 years of experience of experience
• Trained at MD Anderson Cancer Center and Moffitt Cancer Center
• Previously worked at Karadeniz Technical University Medical Oncology Clinic
• Expert in treating various urologic cancers including bladder cancer

Dr. Kaplan specializes in radiation oncology for bladder cancer at Medipol Mega University Hospital.

• Focuses on precise radiation therapy techniques
• Works at a leading university hospital
• Dedicated to personalized treatment plans

Associate Professor Dr. Yusuf Acikgoz brings international oncology experience from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on bladder cancer
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO)

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, treating patients at Istinye University Liv Hospital Bahcesehir.

• Trained in internal medicine at Malatya State Hospital
• Worked at Ankara Oncology Clinic with a focus on oncology
• Member of the oncology department at Erzurum Regional Training and Research Hospital
• Associated professor since 2016

Professor Cemil Bilir specializes in bladder cancer with extensive training at prestigious institutions like Cleveland Clinic and Northeastern University.

• Board-certified in medical oncology with over 21 years of experience of experience
• Member of ASCO and ESMO – follows international treatment guidelines
• Conducts research in pharmaceutical biotechnology for advanced therapies
• Professor at Sakarya University – trains future oncologists

Assoc. Prof. Nail Paksoy specializes in bladder cancer treatment at Medipol Bahçelievler Hospital, bringing extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Participated in multiple international clinical trials for urothelial carcinoma
• Published research on prognostic factors in metastatic bladder cancer
• Fellowship-trained at Istanbul University Oncology Institute

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Alemdar specializes in bladder cancer treatment with a strong academic background and extensive hospital experience.

• Trained in medical oncology at Akdeniz University
• Years of experience across multiple prestigious hospitals
• Focuses on personalized treatment plans

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Ozden specializes in bladder cancer treatment with extensive training in medical oncology at Kocaeli University Faculty of Medicine.

• Over 27 years of experience of experience in internal medicine and oncology
• Trained at Istanbul University, one of Turkey's top medical schools
• Expert in chemotherapy and immunotherapy protocols for bladder cancer

Dr. Yurdakul specializes in uro-oncology with advanced training from Cleveland Clinic Ohio and University of Pittsburgh, focusing on bladder cancer treatments.

• 76 years of experience of experience in urology and uro-oncology
• Published 16 international and 58 national scientific articles
• Trained in microvascular surgery at Mercy University
• Speaker and session chairman at national urology meetings

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Assoc. Prof. Serap Kaya brings specialized oncology expertise from academic hospitals to Emsey Hospital.

• Specialized in Medical Oncology at Kocaeli University
• Practiced at Kartal Dr. Lütfi Kırdar Training and Research Hospital
• Current faculty member at Emsey Hospital
• Experienced in both adult and pediatric oncology

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is one of the first five doctors globally to publish results on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed his fellowship at Heidelberg University in Germany. His practice focuses on regenerative medicine and robotic surgery for cancer.

• Developed a surgical technique for penile enhancement with a UK-based certification.
• Introduced combined PRP and stem cell penile injections to Turkey.
• Performs robotic prostatectomies and kidney-sparing surgeries.
• Member of the International Society for Stem Cells Applications.

Dr. Tanriverdi specializes in bladder cancer treatments with a focus on minimally invasive and robotic-assisted techniques.

• 33 years of experience of experience in surgical oncology and urology
• Expertise in robot-assisted laparoscopic urologic surgery
• Member of European Association of Urology and American Urological Association
• 31 international publications on urologic surgeries

Specialized in radiation oncology at Marmara University, Dr. Sahibov focuses on bladder cancer treatment at Emsey Hospital.

• Completed rigorous training at Marmara University's Faculty of Medicine
• Specializes in radiation oncology with a focus on bladder cancer
• Works at Emsey Hospital, a leading center for oncology care